Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Muraglitazar Monotherapy in Type 2 Diabetes
NCT00246987Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of muraglitazar in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started Jun 2003; status: completed.
02
Drugs
muraglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00246987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246987.